InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,617.63
(
0.04%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.74
(
-0.16%
)
Bitcoin
62,530.81
(
0.32%
)

Replies to post #1880 on Ocera Therapeutics fka OCRX

Replies to #1880 on Ocera Therapeutics fka OCRX

DewDiligence

11/02/15 12:57 PM

#1881 RE: edcpf #1880

That's quite realistic, IMO, if the STOP-HE trial is successful or (less likely, but possible) if OCRX inks a lucrative partnership to commercialize the IV and oral forms of OCR-002. Regards, Dew